Opko Health Inc (NASDAQ: OPK) kicked off on Friday, down -2.14% from the previous trading day, before settling in for the closing price of $1.4. Over the past 52 weeks, OPK has traded in a range of $1.21-$2.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 32.04%. While this was happening, its average annual earnings per share was recorded -335.42%. With a float of $350.18 million, this company’s outstanding shares have now reached $671.61 million.
Let’s determine the extent of company efficiency that accounts for 2997 employees. In terms of profitability, gross margin is 32.12%, operating margin of -21.43%, and the pretax margin is -0.08%.
Opko Health Inc (OPK) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Opko Health Inc is 55.84%, while institutional ownership is 31.96%. The most recent insider transaction that took place on Apr 10 ’25, was worth 169,712. In this transaction CEO & Chairman of this company bought 125,000 shares at a rate of $1.36, taking the stock ownership to the 214,001,448 shares. Before that another transaction happened on Apr 08 ’25, when Company’s CEO & Chairman bought 125,000 for $1.48, making the entire transaction worth $184,650. This insider now owns 213,876,448 shares in total.
Opko Health Inc (OPK) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -335.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.00% during the next five years compared to 32.04% growth over the previous five years of trading.
Opko Health Inc (NASDAQ: OPK) Trading Performance Indicators
Take a look at Opko Health Inc’s (OPK) current performance indicators. Last quarter, stock had a quick ratio of 2.28. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.08, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Opko Health Inc (OPK)
Looking closely at Opko Health Inc (NASDAQ: OPK), its last 5-days average volume was 3.14 million, which is a drop from its year-to-date volume of 3.95 million. As of the previous 9 days, the stock’s Stochastic %D was 63.89%.
During the past 100 days, Opko Health Inc’s (OPK) raw stochastic average was set at 19.39%, which indicates a significant decrease from 38.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0508 in the past 14 days, which was lower than the 0.0613 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3381, while its 200-day Moving Average is $1.4998. However, in the short run, Opko Health Inc’s stock first resistance to watch stands at $1.3905. Second resistance stands at $1.4111. The third major resistance level sits at $1.4263. If the price goes on to break the first support level at $1.3547, it is likely to go to the next support level at $1.3395. Should the price break the second support level, the third support level stands at $1.3189.
Opko Health Inc (NASDAQ: OPK) Key Stats
The company with the Market Capitalisation of 1.09 billion has total of 793,053K Shares Outstanding. Its annual sales at the moment are 713,140 K in contrast with the sum of -53,220 K annual income. Company’s last quarter sales were recorded 149,950 K and last quarter income was -67,610 K.
